WallStreetZenWallStreetZen

NASDAQ: DTIL
Precision Biosciences Inc Stock Ownership - Who owns Precision Biosciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Precision Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael AmorosoPresident and CEO2026-01-2234,799$4.17
$145.11kSell
John Alexander KellyChief Financial Officer2026-01-2115,213$4.03
$61.31kSell
J. Jefferson SmithChief Research Officer2026-01-2110,200$4.03
$41.11kSell
Dario ScimecaGeneral Counsel and Secretary2026-01-218,854$4.03
$35.68kSell
Stanley FrankelDirector2025-12-162,700$4.70
$12.69kBuy
Geno J. GermanoDirector2025-12-163,000$4.72
$14.16kBuy
Melinda BrownDirector2025-12-151,381$4.97
$6.86kBuy
Michael AmorosoPresident and CEO2025-11-033,409$6.49
$22.12kSell
Dario ScimecaGeneral Counsel and Secretary2025-11-03665$6.49
$4.32kSell
John Alexander KellyChief Financial Officer2025-11-031,303$6.49
$8.46kSell

1 of 3

DTIL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DTIL insiders and whales buy or sell their stock.

DTIL Shareholders

What type of owners hold Precision Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Pharma Ag Novartis93.59%12,407,440$44.29MInsider
Venbio Global Strategic Fund LP32.17%4,265,141$15.23MInsider
Derek Jantz30.59%4,055,174$14.48MInsider
Fmr LLC28.20%3,738,248$13.35MInsider
Matthew R. Kane15.27%2,024,438$7.23MInsider
Bleichroeder LP8.11%1,075,000$3.84MInstitution
Lynx1 Capital Management LP7.86%1,042,596$3.72MInstitution
Tang Capital Management LLC4.93%653,649$2.33MInstitution
Vanguard Group Inc3.72%492,596$1.76MInstitution
Renaissance Technologies LLC1.48%196,177$700.35kInstitution

1 of 3

DTIL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DTIL14.41%85.59%Net SellingNet Selling
GRCE26.23%49.85%
LIMN0.97%85.86%
IBO0.51%2.54%Net Selling
INKT0.38%99.62%Net BuyingNet Buying
View Top Biotech Stocks

Precision Biosciences Stock Ownership FAQ

Who owns Precision Biosciences?

Precision Biosciences (NASDAQ: DTIL) is owned by 35.07% institutional shareholders, 208.34% Precision Biosciences insiders, and 0.00% retail investors. Pharma Ag Novartis is the largest individual Precision Biosciences shareholder, owning 12.41M shares representing 93.59% of the company. Pharma Ag Novartis's Precision Biosciences shares are currently valued at $47.15M.

If you're new to stock investing, here's how to buy Precision Biosciences stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.